1. National Kidney Foundation. KDOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(Suppl 3):S1–202.
2. Kidney disease: improving global outcomes (KDIGO) CKD–MBD work group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD). Kidney Int. 2009;76(Suppl 113):S1–130.
3. Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-MBD. Am J Kidney Dis. 2010;55(5):773–99.
4. Manns BJ, Hodsman A, Zimmerman DL, Mendelssohn DC, Soroka SD, Chan C, et al. Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2010;55(5):800–12.
5. Goldsmith DJA, Covic A, Fouque D, Locatelli F, Olgaard K, Rodriquez M, et al. Editorial review: endorsement of the kidney disease improving global outcomes (KDIGO) chronic kidney disease–mineral and Bone disorder (CKD-MBD) guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol Dial Transplant. 2010;10:1093.